Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3

Sponsor Class

NETWORK 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 24Lymphoma 13Leukemia 13Lymphoma, Follicular 12Rectal Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Congenital Abnormalities 7Ovarian Neoplasms 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Acute 6Kidney Neoplasms 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Neuroblastoma 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Central Nervous System Neoplasms 5Adenocarcinoma of Lung 5

Interventions

Carboplatin 31Paclitaxel 26Radiotherapy 23Bevacizumab 19Erlotinib Hydrochloride 16Cisplatin 14Gemcitabine 12Gefitinib 11Docetaxel 11Taxes 9Pemetrexed 9Etoposide 5pegfilgrastim 4Radiotherapy, Conformal 4Radiation 4Neoadjuvant Therapy 4Chemotherapy, Adjuvant 4Cetuximab 4Vinorelbine 3Amplified Fragment Length Polymorphism Analysis 3Topotecan 2Thalidomide 2Sorafenib 2Radiosurgery 2Pharmacogenomic Testing 2Nivolumab 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gene Expression Profiling 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01557959 2018-06-29

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Wake Forest University Health Sciences

Phase 2 Completed
45 enrolled 9 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00897533 2017-05-19

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Eastern Cooperative Oncology Group

Completed
137 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡